Cargando…
Epigenetic modifications and targeted therapy in pediatric acute myeloid leukemia
Acute myeloid leukemia (AML) is a hematological malignancy resulting from the genetic alterations and epigenetic dysregulations of the hematopoietic progenitor cells. One-third of children with AML remain at risk of relapse even though outcomes have improved in recent decades. Epigenetic dysregulati...
Autores principales: | Xu, Huan, Wen, Yuxi, Jin, Runming, Chen, Hongbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485478/ https://www.ncbi.nlm.nih.gov/pubmed/36147798 http://dx.doi.org/10.3389/fped.2022.975819 |
Ejemplares similares
-
Genetic and Epigenetic Targeting Therapy for Pediatric Acute Lymphoblastic Leukemia
por: Xu, Huan, et al.
Publicado: (2021) -
Epigenetic Modifications in Pediatric Acute Lymphoblastic Leukemia
por: Burke, Michael J., et al.
Publicado: (2014) -
Novel Treatments for Pediatric Relapsed or Refractory Acute B-Cell Lineage Lymphoblastic Leukemia: Precision Medicine Era
por: Mengxuan, Shang, et al.
Publicado: (2022) -
Interactions Between Gut Microbiota and Acute Childhood Leukemia
por: Wen, Yuxi, et al.
Publicado: (2019) -
Pediatric Acute Myeloid Leukemia (AML): From Genes to Models Toward Targeted Therapeutic Intervention
por: Mercher, Thomas, et al.
Publicado: (2019)